![Christopher Astle](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Astle
Directeur/Membre du Conseil chez
Oak Bay Biosciences, Inc.
Profil
Christopher Astle was the founder of Think Forwards, a company founded in 2017 where he held the title of Chief Executive Officer from 2017 to 2020.
He is currently working as a Director at Oak Bay Biosciences, Inc. since 2020 and as a Director at Healome Therapeutics Ltd. since 2021.
In his former positions, Dr. Astle worked as Vice President-Finance at Lundbeck Seattle BioPharmaceuticals, Inc. from 2019 to 2020, Associate VP-International Division Finance at Allergan (Canada) from 2016 to 2017, Chief Financial Officer at CFO Centre Ltd. from 2020 to 2021, Senior VP, Chief Financial & Accounting Officer at Zymeworks, Inc. from 2022 to 2024, and Chief Financial Officer & Senior Vice President at Zymeworks BC, Inc. from 2022 to 2024.
Dr. Astle obtained a graduate degree from The University of Liverpool and a doctorate degree from the University of Bristol.
Postes actifs de Christopher Astle
| Sociétés | Poste | Début |
|---|---|---|
Oak Bay Biosciences, Inc. | Directeur/Membre du Conseil | 01/01/2020 |
Healome Therapeutics Ltd.
 Healome Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that develops treatment for eye conditions | Directeur/Membre du Conseil | 01/01/2021 |
Anciens postes connus de Christopher Astle
| Sociétés | Poste | Fin |
|---|---|---|
Zymeworks BC, Inc.
 Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Directeur Financier/CFO | 01/09/2024 |
| ZYMEWORKS INC. | Directeur Financier/CFO | 31/03/2024 |
CFO Centre Ltd.
 CFO Centre Ltd. Personnel ServicesCommercial Services Provides temporary staffing services | Directeur Financier/CFO | 01/03/2021 |
| ALDER BIOPHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/02/2020 |
Think Forwards | Directeur Général | 01/01/2020 |
Formation de Christopher Astle
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
10
Relations au 1er degré
10
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Develops protein therapeutics for the treatment of cancer, autoimmune and inflammatory diseases | Health Technology |
The University of Liverpool
 The University of Liverpool Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Bristol
 University of Bristol Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Lundbeck Seattle BioPharmaceuticals, Inc.
 Lundbeck Seattle BioPharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that specializes in research and develops transformative therapies for brain diseases | Health Technology |
Allergan (Canada)
 Allergan (Canada) Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
CFO Centre Ltd.
CFO Centre Ltd. Personnel ServicesCommercial Services Provides temporary staffing services | Commercial Services |
Think Forwards | |
Oak Bay Biosciences, Inc. | |
Healome Therapeutics Ltd.
Healome Therapeutics Ltd. BiotechnologyHealth Technology Operates as a clinical stage company that develops treatment for eye conditions | Health Technology |
Zymeworks, Inc.
 Zymeworks, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
